|Bid||34.00 x 800|
|Ask||71.18 x 900|
|Day's Range||67.81 - 69.17|
|52 Week Range||55.21 - 88.78|
|Beta (5Y Monthly)||0.71|
|PE Ratio (TTM)||60.82|
|Forward Dividend & Yield||0.21 (0.31%)|
|Ex-Dividend Date||May 03, 2022|
|1y Target Est||N/A|
Alcon Inc.'s ( VTX:ALC ) price-to-earnings (or "P/E") ratio of 60.1x might make it look like a strong sell right now...
Alcon's (ALC) ophthalmic pharmaceutical product suite is expected to be significantly boosted by adding new products following the recent acquisition.
Alcon's (ALC) robust innovation pipeline is delivering solid results as evidenced by the strength in its comprehensive portfolio of PCIOLs, including PanOptix and Vivity.